教職人員
|
蕭斐元
研究領域：藥物流行病學、藥事經濟學、健康照護研究
本職：教授
| 最高學歷 | : | National Yang-Ming University, School of Public Health, Taiwan Ph.D. in Health and Welfare Policy Management, July 2007 (Concentration in pharmacoepidemiology and pharmacoeconomics) Taipei Medical University, School of Pharmacy, Taiwan M.S. in Clinical Pharmacy, June 2003 Taipei Medical University, School of Pharmacy, Taiwan B.S. in Pharmacy, June 2001 |
| 經歷 | : | Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, MD, USA. Post-doctoral fellow, August 2008-July2010 Institute of Health and Welfare Policy, National Yang-Ming University, Taiwan. Post-doctoral fellow, September 2007-August 2008 |
| 榮譽 | : | Ronald D. Mann Best Paper Award, First Prize, 2016 National Taiwan University, Excellent Paper Award, 2012, 2013, 2014, 2015 National Taiwan University, A-level Paper Award, 2012, 2013, 2014, 2015 National Taiwan University, Grant Award, 2014, The Drug Information Association (DIA) Student Poster Travel Grant, 2009 National Science Council (Taiwan) Postdoctoral Fellowship, 2008-2009 International Pharmaceutical Federation-Western Pacific Pharmaceutical Forum (FIP–WPPF) Travel Grant, 2006 |
| 研究領域 | : | 藥物流行病學、藥事經濟學、健康照護研究 |
| 研究方向 | : | 1.藥品上市後安全監視 2.老年藥物流行病學 3.疾病負擔與經濟評估 4.大型健保資料庫分析與觀察性研究 |
| 研究室要求 | : | 真誠負責 |
| 研究室成員 | : | 1.目前成員 研究助理 林芝琬2015.08- 莊賢業2016.09- 藥學研究所 博士班學生 王貞予 臨床藥學研究所 碩士班學生 (R04)廖愷欣 (R05)黃世宗 2.畢業學生及助理 研究助理 謝佩樺2011.09-2013.02 周欣諄2012.06-2015.08 陳虹霖2013.09-2015.08 呂宛璇2014.09-2015.12 溫燿駿2015.12-2017.05 施怡如2016.02-2017.06 臨床藥學研究所 碩士班學生 (R03)莊賢業2015.08-2016.08 (R02)林芝琬2014.08-2015.08 (R02)許雯涵2014.08-2015.08 (R01)王貞予2013.08-2014.08 (R01)呂宛璇2013.08-2014.08 (R00)溫存真2012.08-2013.08 (R99)陳虹霖2012.08-2013.08 (R99)林婉婷2011.08-2012.08 (R99)周丹薇2011.08-2012.08 共同指導 碩士班學生/主要指導老師 (R05)洪佳安2016/林淑文 (R03)簡彤凌2015/林淑文 (R03)黃子藍2015/沈麗娟 (R02)溫燿駿2014/沈麗娟 (R02)董曼翎2014/林淑文 (R01)陳俐如2013/林淑文 (R01)林佳慧2013/沈麗娟 (R00)張鈺敏2012/林淑文 (R00)陳冠霖2012/沈麗娟 (R00)許瀞尹2012/沈麗娟 (R98)謝佩樺2010/高純琇 (R98)陳世芹2010/高純琇 |
| 招生名額 | : | 臨床藥學研究所 碩士班學生和博士班學生 (Graduate Institute of Clinical Pharmacy) |
Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial
(2025) Chen, Li-Yu ; Liao, Ling-Chiao ; Chuang, Chin-Ju ; Hsieh, Cheng-Ying ; Huang, Yung-Cheng ; YI-HSUAN YANG ; Chang, Wan-Ting ; Fu, Shau-Huai ; FENG-JUNG YANG ; Chang, Kai-Chieh ; DING-CHENG CHAN ; LI-JIUAN SHEN ; FEI-YUAN HSIAO ; Huang, Yen-Ming ; Hsu, Chih-Cheng ; Wang, Chen-Yu
Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study.
(2024-09) FEI-YUAN HSIAO ; Tan, Elise Chia-Hui ; Meng, Lin-Chieh ; Lin, Yi-Chin ; Chen, Ho-Min ; Guan, Shang-Ting ; Tarng, Der-Cherng ; Chen, Liang-Kung ; CHIH-YUAN WANG
Concomitant use of antidepressants and benzodiazepines during pregnancy and associated risk of congenital malformations: a population-based cohort study in Taiwan
(2024-08) Chuang, Hui-Min ; Meng, Lin-Chieh ; Lin, Chih-Wan ; Chen, Wen-Wen ; Chen, Yi-Yung ; CHI-YUNG SHANG ; Chen, Liang-Kung ; FEI-YUAN HSIAO
Recurrence of Diabetic Foot Complications: A Domino Effect Leading to Lethal Consequences-Insights From a National Longitudinal Study.
(2024-06) Hsu, Chun-Chien ; Lai, Hsi-Yu ; Lin, Hung-Yu ; SUNG-CHING PAN ; Chen, Liang-Kung ; NAI-CHEN CHENG ; FEI-YUAN HSIAO ; SHU-WEN LIN
Prescription Patterns and Predisposing Factors of Benzodiazepine and Z-Hypnotic Use During Pregnancy: A Nationwide Cohort Study
(2024-06) Meng, Lin-Chieh ; Lin, Chih-Wan ; Chuang, Hui-Min ; Chen, Yi-Yung ; CHI-YUNG SHANG ; CHIA-YI WU ; Chen, Liang-Kung ; FEI-YUAN HSIAO
(2025) Chen, Li-Yu ; Liao, Ling-Chiao ; Chuang, Chin-Ju ; Hsieh, Cheng-Ying ; Huang, Yung-Cheng ; YI-HSUAN YANG ; Chang, Wan-Ting ; Fu, Shau-Huai ; FENG-JUNG YANG ; Chang, Kai-Chieh ; DING-CHENG CHAN ; LI-JIUAN SHEN ; FEI-YUAN HSIAO ; Huang, Yen-Ming ; Hsu, Chih-Cheng ; Wang, Chen-Yu
Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study.
(2024-09) FEI-YUAN HSIAO ; Tan, Elise Chia-Hui ; Meng, Lin-Chieh ; Lin, Yi-Chin ; Chen, Ho-Min ; Guan, Shang-Ting ; Tarng, Der-Cherng ; Chen, Liang-Kung ; CHIH-YUAN WANG
Concomitant use of antidepressants and benzodiazepines during pregnancy and associated risk of congenital malformations: a population-based cohort study in Taiwan
(2024-08) Chuang, Hui-Min ; Meng, Lin-Chieh ; Lin, Chih-Wan ; Chen, Wen-Wen ; Chen, Yi-Yung ; CHI-YUNG SHANG ; Chen, Liang-Kung ; FEI-YUAN HSIAO
Recurrence of Diabetic Foot Complications: A Domino Effect Leading to Lethal Consequences-Insights From a National Longitudinal Study.
(2024-06) Hsu, Chun-Chien ; Lai, Hsi-Yu ; Lin, Hung-Yu ; SUNG-CHING PAN ; Chen, Liang-Kung ; NAI-CHEN CHENG ; FEI-YUAN HSIAO ; SHU-WEN LIN
Prescription Patterns and Predisposing Factors of Benzodiazepine and Z-Hypnotic Use During Pregnancy: A Nationwide Cohort Study
(2024-06) Meng, Lin-Chieh ; Lin, Chih-Wan ; Chuang, Hui-Min ; Chen, Yi-Yung ; CHI-YUNG SHANG ; CHIA-YI WU ; Chen, Liang-Kung ; FEI-YUAN HSIAO
Exposure to Cns Drugs during Pregnancy on Short- and Long-Term Maternal and Neonatal Adverse Outcomes
(2023-08-01～) FEI-YUAN HSIAO
Exposure to Cns Drugs during Pregnancy on Short- and Long-Term Maternal and Neonatal Adverse Outcomes
(2022-08-01～) FEI-YUAN HSIAO
Exposure to Cns Drugs during Pregnancy on Short- and Long-Term Maternal and Neonatal Adverse Outcomes
(2021-08-01～) FEI-YUAN HSIAO
Cardiovascular Toxic Effects of Targeted Therapies for Hematologic Malignancies=血液腫瘤標靶治療藥物之心臟血管毒性
(2021-08-01～) FEI-YUAN HSIAO
Cardiovascular Toxic Effects of Targeted Therapies for Hematologic Malignancies=血液腫瘤標靶治療藥物之心臟血管毒性
(2020-08-01～) FEI-YUAN HSIAO
(2023-08-01～) FEI-YUAN HSIAO
Exposure to Cns Drugs during Pregnancy on Short- and Long-Term Maternal and Neonatal Adverse Outcomes
(2022-08-01～) FEI-YUAN HSIAO
Exposure to Cns Drugs during Pregnancy on Short- and Long-Term Maternal and Neonatal Adverse Outcomes
(2021-08-01～) FEI-YUAN HSIAO
Cardiovascular Toxic Effects of Targeted Therapies for Hematologic Malignancies=血液腫瘤標靶治療藥物之心臟血管毒性
(2021-08-01～) FEI-YUAN HSIAO
Cardiovascular Toxic Effects of Targeted Therapies for Hematologic Malignancies=血液腫瘤標靶治療藥物之心臟血管毒性
(2020-08-01～) FEI-YUAN HSIAO